The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase III study (CheckMate 017) of nivolumab (NIVO; anti-programmed death-1 [PD-1]) vs docetaxel (DOC) in previously treated advanced or metastatic squamous (SQ) cell non-small cell lung cancer (NSCLC).
 
David R. Spigel
No Relationships to Disclose
 
Karen L. Reckamp
Consulting or Advisory Role - Amgen; Boehringer Ingelheim; Bristol-Myers Squibb
Research Funding - ARIAD; Astellas Pharma; Bristol-Myers Squibb; Celgene; Clovis Oncology; Eisai; Gilead Sciences; GlaxoSmithKline; Novartis; Pfizer; Xcovery
 
Naiyer A. Rizvi
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Merck; Roche Pharma AG
Research Funding - Bristol-Myers Squibb
 
Elena Poddubskaya
No Relationships to Disclose
 
Howard Jack West
Honoraria - Celgene; Foundation Medicine; Genentech/Roche; Merck; Novartis; Pfizer
Consulting or Advisory Role - Celgene; Foundation Medicine; Genentech/Roche; Merck; Novartis; Pfizer
Travel, Accommodations, Expenses - Celgene; Foundation Medicine; Genentech/Roche; Merck; Novartis; Novartis
 
Wilfried Ernst Erich Eberhardt
Honoraria - Amgen; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; GlaxoSmithKline; Lilly; Merck; Novartis; Pfizer; Roche Pharma AG
Consulting or Advisory Role - Amgen; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; GlaxoSmithKline; Lilly; Merck; Novartis; Pfizer; Roche Pharma AG
Research Funding - Lilly
 
Paul Baas
Honoraria - Verastem
Consulting or Advisory Role - Bristol-Myers Squibb; Merck; Pfizer; Verastem
Research Funding - Bristol-Myers Squibb (Inst); Merck (Inst); Pfizer (Inst)
 
Scott Joseph Antonia
Honoraria - AstraZeneca; Bristol-Myers Squibb
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb
 
Adam Pluzanski
Consulting or Advisory Role - Boehringer Ingelheim; Bristol-Myers Squibb
Research Funding - Amgen; Bristol-Myers Squibb; Pfizer
 
Everett E. Vokes
Consulting or Advisory Role - Abbvie; AstraZeneca; Boehringer Ingelheim; Celgene; Clovis Oncology; Eisai; GeneCentric; Genentech; Lilly; Merck; Synta; Transgene; VentiRx
 
Esther Holgado
Honoraria - Roche Pharma AG
Consulting or Advisory Role - Roche Pharma AG
Travel, Accommodations, Expenses - Merck Serono; Roche Pharma AG
 
David Michael Waterhouse
Consulting or Advisory Role - Lilly; Veristat
Speakers' Bureau - Genentech/Roche; Lilly
 
Neal Ready
Consulting or Advisory Role - Bristol-Myers Squibb; Onyx
Research Funding - Bristol-Myers Squibb; Genentech
 
Justin F. Gainor
No Relationships to Disclose
 
Osvaldo Rudy Aren
Consulting or Advisory Role - Boehringer Ingelheim; Bristol-Myers Squibb; Roche Pharma AG
 
Leora Horn
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Clovis Oncology; Helix BioPharma; Merck; Puma Biotechnology
Research Funding - Astellas Pharma (Inst)
Travel, Accommodations, Expenses - Boehringer Ingelheim
 
Luis Paz-Ares
Honoraria - Bristol-Myers Squibb
 
Christine Baudelet
Employment - Bristol-Myers Squibb
 
Brian Joseph Lestini
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Julie R. Brahmer
Consulting or Advisory Role - Bristol-Myers Squibb; Lilly; Merck KGaA
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Merck (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck
Other Relationship - Bristol-Myers Squibb